Alanyl-tRNA Synthetase-like Enzyme-Catalyzed Aminoacylation in Nucleoside Sulfamate Ascamycin Biosynthesis

Yu Zheng,Naoko Morita,Hiroshi Takagi,Yumi Shiozaki-Sato,Jun Ishikawa,Kazuo Shin-ya,Shunji Takahashi
DOI: https://doi.org/10.1021/acscatal.3c05667
IF: 12.9
2024-02-20
ACS Catalysis
Abstract:The adenosine 5′-monophosphate-mimicking nucleoside sulfamates are pharmaceutically important compounds that target aminoacyl-tRNA synthetases (aaRSs) and other adenylate-forming enzymes. Ascamycin (1) is a unique naturally occurring alanyl adenosine sulfamate isolated from Streptomyces sp. 80H647. In this study, we successfully enhanced the in vivo conversion of dealanylascamycin (2) to ascamycin by constitutively expressing an extra copy of bldA and adpA regulatory genes. More importantly, we performed gene expression analysis and protein structure–function prediction to identify alanyl-tRNA synthetase (AlaRS)-like enzymes: AcmF and AcmD. AcmF efficiently catalyzes the aminoacylation reaction during ascamycin biosynthesis, and this reaction is dependent on the Ala-tRNAAla supplied by AcmD. AcmF is a truncated AlaRS-like enzyme containing only the aminoacylation and tRNA recognition domains, whereas AcmD has an intact AlaRS-like architecture that efficiently supports AcmF activity by exhibiting resistance to the AcmF-produced ascamycin. In addition, we have produced the glycyl- and seryl-derivatives of ascamycin using the AcmD-AcmF enzyme pair. The mechanistic study identified Glu232 and several residues that play important roles in AcmF catalysis. To the best of our knowledge, AcmF is a representative class II aaRS-like enzyme catalyzing tRNA-dependent aminoacylation during natural product biosynthesis. These findings provide a potential chemoenzymatic approach for the synthesis of aminoacyl nucleoside sulfamates.
chemistry, physical
What problem does this paper attempt to address?